CONMED (NYSE:CNMD) Issues Q3 2024 Earnings Guidance

CONMED (NYSE:CNMD – Get Free Report) issued an update on its third quarter 2024 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of 0.980-1.000 for the period, compared to the consensus estimate of 0.990. The company issued revenue guidance of $315.0 million-$318.0 million, compared to the consensus revenue estimate of […]

Leave a Reply

Your email address will not be published.

Previous post OSRAM Licht AG (OTCMKTS:OSAGY) Increases Dividend to $1.04 Per Share
Next post Insider Selling: Disc Medicine, Inc. (NASDAQ:IRON) Director Sells $10,313.31 in Stock